NCT05066256

Brief Summary

Fluid responsive is defined as increasing in Cardiac output or Stroke volume by 10-15% after fluid challenge. Left ventricular diastolic dysfunction is associated with lower left ventricular end-diastolic volume (LVEDV) resulting in a less cardiac output increment after fluid challenge. However, Left ventricular diastolic function indicated by the Mitral E/e' ratio from transthoracic echocardiography, was rarely studied for fluid responsiveness evaluation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 23, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 4, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

October 4, 2021

Status Verified

September 1, 2021

Enrollment Period

2.9 years

First QC Date

September 23, 2021

Last Update Submit

October 1, 2021

Conditions

Keywords

shockfluid responsivenessleft ventricular diastolic dysfunctionMitral E/e'

Outcome Measures

Primary Outcomes (1)

  • Fluid responsiveness

    Fluid responsiveness defined by increase in cardiac output at least 15% or increase in systolic blood pressure at least 10 mmHg or increase in mean arterial pressure at least 5 mmHg.

    6 hours

Study Arms (1)

Fluid responsive test

EXPERIMENTAL

Measure cardiac output, inferior vena cava (IVC) diameter variation and LV diastolic function (E/e') baseline Fluid challenge Measure cardiac output, IVC diameter variation and LV diastolic function (E/e') after fluid challenge

Diagnostic Test: Left ventricular diastolic functionDiagnostic Test: Inferior vena cava variation

Interventions

Transthoracic echocardiography Mitral E/e'

Also known as: Mitral E/e'
Fluid responsive test

Inferior vena cava variation from ultrasound

Also known as: IVC variation
Fluid responsive test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age more than 18 years
  • Diagnosis of shock defined by systolic blood pressure \< 90 mmHg or mean arterial blood pressure \< 65 mmHg and/or clinical hypoperfusion
  • Mechanically ventilated without ventilator dyssynchrony and no ventilator triggering
  • Present of central venous cather or arterial catheter

You may not qualify if:

  • Age \< 18 years
  • Frankly hypovolemic shock or hemorrhagic shock
  • Suspicious of cardiogenic shock
  • Suspicious of acute decompensated heart failure
  • Suspicious of acute coronary syndrome
  • Denied participation or denied inform consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, 10700, Thailand

RECRUITING

MeSH Terms

Conditions

ShockShock, SepticVentricular Dysfunction, Left

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsSepsisInfectionsSystemic Inflammatory Response SyndromeInflammationVentricular DysfunctionHeart DiseasesCardiovascular Diseases

Study Officials

  • Surat Tongyoo

    Mahidol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Pre-experimental study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2021

First Posted

October 4, 2021

Study Start

September 22, 2021

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

October 4, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will share

Anonymus participant data will be available after request with ethical committee approval.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Within 6 months after study publication
Access Criteria
Request to principal investigator after ethical committee approval

Locations